메뉴 건너뛰기




Volumn 60, Issue 5, 2008, Pages 365-374

Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy

Author keywords

CMV infection; Graft function; Graft survival; Kidney transplantation; Preemptive CMV therapy

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CREATININE; CYCLOSPORIN; DACLIZUMAB; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

EID: 59149090396     PISSN: 00348376     EISSN: 00348376     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (4)

References (32)
  • 1
    • 0242294138 scopus 로고    scopus 로고
    • The impact of cytomegalovirus infection on graft function and patient outcome
    • Tolkoff-Rubin NE, Rubin RH. The impact of cytomegalovirus infection on graft function and patient outcome. Graft 1999; 2: S101-S103.
    • (1999) Graft , vol.2
    • Tolkoff-Rubin, N.E.1    Rubin, R.H.2
  • 2
    • 0032508056 scopus 로고    scopus 로고
    • Infection in organ-transplant recipients
    • Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998; 338: 1741-51.
    • (1998) N Engl J Med , vol.338 , pp. 1741-1751
    • Fishman, J.A.1    Rubin, R.H.2
  • 3
    • 0033302594 scopus 로고    scopus 로고
    • Indirect effects of CMV in the solid organ transplant patient
    • Paya CV. Indirect effects of CMV in the solid organ transplant patient. Transpl Infect Dis 1999; 1(Suppl. 1): 8-12.
    • (1999) Transpl Infect Dis , vol.1 , Issue.SUPPL. 1 , pp. 8-12
    • Paya, C.V.1
  • 4
    • 0035428084 scopus 로고    scopus 로고
    • Cytomegalovirus infection in immunocompetent and immunocompromised individuals-a review
    • Vancíková Z, Dvorák P. Cytomegalovirus infection in immunocompetent and immunocompromised individuals-a review. Curr Drug Targets Immune Endocr Metabol Disord 2001; 1: 179-87.
    • (2001) Curr Drug Targets Immune Endocr Metabol Disord , vol.1 , pp. 179-187
    • Vancíková, Z.1    Dvorák, P.2
  • 5
    • 0025042563 scopus 로고
    • Impact of cytomegalovirus infection on organ transplant recipients
    • Rubin RH. Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 1990; 12(Suppl. 7): S754-S766.
    • (1990) Rev Infect Dis , vol.12 , Issue.SUPPL. 7
    • Rubin, R.H.1
  • 6
    • 0036657140 scopus 로고    scopus 로고
    • Cytomegalovirus infections in kidney transplant patients
    • Babel N, Kern F, Volk HD, Reinke P. Cytomegalovirus infections in kidney transplant patients. Transplant Rev 2002; 16: 121-30.
    • (2002) Transplant Rev , vol.16 , pp. 121-130
    • Babel, N.1    Kern, F.2    Volk, H.D.3    Reinke, P.4
  • 7
    • 0032573740 scopus 로고    scopus 로고
    • A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients
    • Flechner SM, Avery RK, Fisher R, Mastroianni BA, Papajcik DA, O'Malley KJ, et al. A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Transplantation 1998; 66: 1682-8.
    • (1998) Transplantation , vol.66 , pp. 1682-1688
    • Flechner, S.M.1    Avery, R.K.2    Fisher, R.3    Mastroianni, B.A.4    Papajcik, D.A.5    O'Malley, K.J.6
  • 8
    • 0033551348 scopus 로고    scopus 로고
    • Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group
    • Lowance D, Neumayer HH, Legendre CM, Squiffiet JP, Kovarik J, Brennan PJ, et al. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. N Engl J Med 1999; 340: 1462-70.
    • (1999) N Engl J Med , vol.340 , pp. 1462-1470
    • Lowance, D.1    Neumayer, H.H.2    Legendre, C.M.3    Squiffiet, J.P.4    Kovarik, J.5    Brennan, P.J.6
  • 9
    • 1942469969 scopus 로고    scopus 로고
    • Valganciclovir Solid Organ Transplant Study Group. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients
    • Paya C, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, et al. Valganciclovir Solid Organ Transplant Study Group. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2004; 4: 611-20.
    • (2004) Am J Transplant , vol.4 , pp. 611-620
    • Paya, C.1    Humar, A.2    Dominguez, E.3    Washburn, K.4    Blumberg, E.5    Alexander, B.6
  • 10
    • 33746895463 scopus 로고    scopus 로고
    • Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients
    • Khoury JA, Storch GA, Bohl DL, Schuessler RM, Torrence SM, Lockwood M, et al. Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients. Am J Transplant 2006; 6: 2134-43.
    • (2006) Am J Transplant , vol.6 , pp. 2134-2143
    • Khoury, J.A.1    Storch, G.A.2    Bohl, D.L.3    Schuessler, R.M.4    Torrence, S.M.5    Lockwood, M.6
  • 11
    • 0030725003 scopus 로고    scopus 로고
    • Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapy
    • Brennan DC, Garlock KA, Lippmann BA, Buller RS, Gaudreault-Keener M, Lowell JA, et al. Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapy. J Am Soc Nephrol 1997; 8: 118-25.
    • (1997) J Am Soc Nephrol , vol.8 , pp. 118-125
    • Brennan, D.C.1    Garlock, K.A.2    Lippmann, B.A.3    Buller, R.S.4    Gaudreault-Keener, M.5    Lowell, J.A.6
  • 12
    • 0034686916 scopus 로고    scopus 로고
    • Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants
    • Limaye AP, Corey L, Koelle DM, Davis CL, Boeckh M. Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants. Lancet 2000; 356: 645-9.
    • (2000) Lancet , vol.356 , pp. 645-649
    • Limaye, A.P.1    Corey, L.2    Koelle, D.M.3    Davis, C.L.4    Boeckh, M.5
  • 13
    • 0035062921 scopus 로고    scopus 로고
    • Prophylaxis for CMV should not now replace pre-emptive therapy in solid organ transplantation
    • Emery VC. Prophylaxis for CMV should not now replace pre-emptive therapy in solid organ transplantation. Rev Med Virol 2001; 11: 83-6.
    • (2001) Rev Med Virol , vol.11 , pp. 83-86
    • Emery, V.C.1
  • 14
    • 15044349747 scopus 로고    scopus 로고
    • Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: A call to heed the mounting evidence
    • Singh N. Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence. Clin Infect Dis 2005; 40: 704-8.
    • (2005) Clin Infect Dis , vol.40 , pp. 704-708
    • Singh, N.1
  • 15
    • 0025891456 scopus 로고
    • Preemptive therapy in immunocompromised hosts
    • Rubin RH. Preemptive therapy in immunocompromised hosts. N Engl J Med 1991; 324: 1057-9.
    • (1991) N Engl J Med , vol.324 , pp. 1057-1059
    • Rubin, R.H.1
  • 16
    • 0026688077 scopus 로고
    • The TH, van der Ploeg M, van den Berg AP, Vlieger AM, van der Giessen M, van Son WJ. Direct detection of cytomegalovirus in peripheral blood leukocytes - a review of the antigenemia assay and polymerase chain reaction
    • The TH, van der Ploeg M, van den Berg AP, Vlieger AM, van der Giessen M, van Son WJ. Direct detection of cytomegalovirus in peripheral blood leukocytes - a review of the antigenemia assay and polymerase chain reaction. Transplantation 1992; 54: 193-8.
    • (1992) Transplantation , vol.54 , pp. 193-198
  • 17
  • 18
    • 0031464801 scopus 로고    scopus 로고
    • Comparative study of cytomegalovirus (CMV) antigenemia assay, polymerase chain reaction, serology, and shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation
    • Tanabe K, Tokumoto T, Ishikawa N, Koyama I, Takahashi K, Fuchinoue S, et al. Comparative study of cytomegalovirus (CMV) antigenemia assay, polymerase chain reaction, serology, and shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation. Transplantation 1997; 64: 1721-5.
    • (1997) Transplantation , vol.64 , pp. 1721-1725
    • Tanabe, K.1    Tokumoto, T.2    Ishikawa, N.3    Koyama, I.4    Takahashi, K.5    Fuchinoue, S.6
  • 19
    • 0027228036 scopus 로고
    • Early diagnosis of human cytomegalovirus disease in transplant recipients by DNA amplification in plasma
    • Wolf DG, Spector SA. Early diagnosis of human cytomegalovirus disease in transplant recipients by DNA amplification in plasma. Transplantation 1993; 56: 330-4.
    • (1993) Transplantation , vol.56 , pp. 330-334
    • Wolf, D.G.1    Spector, S.A.2
  • 20
    • 0036049260 scopus 로고    scopus 로고
    • Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease
    • Aranda-Verastegui F, Alberu J, Soto-Ramirez LE, Gonzalez-Aguirre H, Munoz Trejo T, Mancilla E, et al. Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease. Rev Invest Clin 2002; 54: 198-203.
    • (2002) Rev Invest Clin , vol.54 , pp. 198-203
    • Aranda-Verastegui, F.1    Alberu, J.2    Soto-Ramirez, L.E.3    Gonzalez-Aguirre, H.4    Munoz Trejo, T.5    Mancilla, E.6
  • 21
    • 0033188569 scopus 로고    scopus 로고
    • Mechanisms of human cytomegalovirus (HCMV) (re)activation and its impact on organ transplant patients
    • Reinke P, Prosch S, Kern F, Volk HD. Mechanisms of human cytomegalovirus (HCMV) (re)activation and its impact on organ transplant patients. Transpl Infect Dis 1999; 1: 157-64.
    • (1999) Transpl Infect Dis , vol.1 , pp. 157-164
    • Reinke, P.1    Prosch, S.2    Kern, F.3    Volk, H.D.4
  • 22
    • 0027475867 scopus 로고
    • Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection
    • Kowalik TF, Wing B, Haskill JS, Azizkhan JC, Baldwin AS Jr, Huang ES. Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection. Proc Natl Acad Sci USA 1993; 90: 1107-11.
    • (1993) Proc Natl Acad Sci USA , vol.90 , pp. 1107-1111
    • Kowalik, T.F.1    Wing, B.2    Haskill, J.S.3    Azizkhan, J.C.4    Baldwin Jr, A.S.5    Huang, E.S.6
  • 23
    • 0034720762 scopus 로고    scopus 로고
    • Rat cytomegalovirus infection in kidney allograft recipients is associated with increased expression of intracellular adhesion molecule-1 vascular adhesion molecule-1, and their ligands leukocyte function antigen-1 and very late antigen-4 in the graft
    • Kloover JS, Soots AP, Krogerus LA, Kauppinen HO, Loginov RJ, Holma KL, et al. Rat cytomegalovirus infection in kidney allograft recipients is associated with increased expression of intracellular adhesion molecule-1 vascular adhesion molecule-1, and their ligands leukocyte function antigen-1 and very late antigen-4 in the graft. Transplantation 2000; 69: 2641-7.
    • (2000) Transplantation , vol.69 , pp. 2641-2647
    • Kloover, J.S.1    Soots, A.P.2    Krogerus, L.A.3    Kauppinen, H.O.4    Loginov, R.J.5    Holma, K.L.6
  • 24
    • 0030738950 scopus 로고    scopus 로고
    • Cytomegalovirus infection induces anti-endothelial cell antibodies in cardiac and renal allograft recipients
    • Toyoda M, Galfayan K, Galera OA, Petrosian A, Czer LS, Jordan SC. Cytomegalovirus infection induces anti-endothelial cell antibodies in cardiac and renal allograft recipients. Transpl Immunol 1997; 5: 104-11.
    • (1997) Transpl Immunol , vol.5 , pp. 104-111
    • Toyoda, M.1    Galfayan, K.2    Galera, O.A.3    Petrosian, A.4    Czer, L.S.5    Jordan, S.C.6
  • 26
    • 0028151190 scopus 로고
    • Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor
    • Fietze E, Prosch S, Reinke P, Stein J, Docke WD, Staffa G, et al. Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor. Transplantation 1994; 58: 675-80.
    • (1994) Transplantation , vol.58 , pp. 675-680
    • Fietze, E.1    Prosch, S.2    Reinke, P.3    Stein, J.4    Docke, W.D.5    Staffa, G.6
  • 27
    • 0029013575 scopus 로고
    • Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial
    • Hibberd PL, Tolkoff-Rubin NE, Conti D, Stuart F, Thistlethwaite JR, Neylan JF, et al. Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial. Ann Intern Med 1995; 123: 18-26.
    • (1995) Ann Intern Med , vol.123 , pp. 18-26
    • Hibberd, P.L.1    Tolkoff-Rubin, N.E.2    Conti, D.3    Stuart, F.4    Thistlethwaite, J.R.5    Neylan, J.F.6
  • 28
    • 0030972577 scopus 로고    scopus 로고
    • Long-term prognosis of renal transplantation after preemptive treatment of cytomegalovirus infection
    • Akposso K, Rondeau E, Haymann JP, Peraldi MN, Marlin C, Sraer JD. Long-term prognosis of renal transplantation after preemptive treatment of cytomegalovirus infection. Transplantation 1997; 63: 974-6.
    • (1997) Transplantation , vol.63 , pp. 974-976
    • Akposso, K.1    Rondeau, E.2    Haymann, J.P.3    Peraldi, M.N.4    Marlin, C.5    Sraer, J.D.6
  • 29
    • 3042808460 scopus 로고    scopus 로고
    • Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival
    • Sagedal S, Hartmann A, Nordal KP, Osnes K, Leivestad T, Foss A, et al. Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival. Kidney Int 2004; 66: 329-37.
    • (2004) Kidney Int , vol.66 , pp. 329-337
    • Sagedal, S.1    Hartmann, A.2    Nordal, K.P.3    Osnes, K.4    Leivestad, T.5    Foss, A.6
  • 31
    • 0038237028 scopus 로고    scopus 로고
    • Tacrolimus: A further update of its use in the management of organ transplantation
    • Scott LJ, McKeage K, Keam SJ, Plosker GL. Tacrolimus: a further update of its use in the management of organ transplantation. Drugs 2003; 63: 1247-97.
    • (2003) Drugs , vol.63 , pp. 1247-1297
    • Scott, L.J.1    McKeage, K.2    Keam, S.J.3    Plosker, G.L.4
  • 32
    • 0031001622 scopus 로고    scopus 로고
    • A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group
    • Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation 1997; 63: 977-83.
    • (1997) Transplantation , vol.63 , pp. 977-983
    • Pirsch, J.D.1    Miller, J.2    Deierhoi, M.H.3    Vincenti, F.4    Filo, R.S.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.